misdiagnosis of a melanotic melanoma pathology Amelanotic Melanocytic Nevus of the

doi: 10.1016/j.brainres.2023.148516 56 ZhangY.-M.DaiQ.-F.ChenW.-H.JiangS.-T.ChenS.-X.ZhangY.-J.et al

Why dual-pathway targeting is more effective Single pathway limitations: GLP-1 alone eventually plateaus Body compensates over time Weight loss slows after 6-12 months Some people don't respond optimally Dual pathway advantages: Harder for body to compensate Multiple redundant systems targeted Sustained weight loss longer Better for non-responders to single therapy Mechanistic synergy: Amylin + GLP-1 naturally work together Both released after meals normally Physiologic combination Not forcing unnatural state Clinical implications: Patients who plateau on semaglutide benefit from adding cagrilintide Initial combination produces maximum results May prevent or delay weight regain Better long-term outcomes Cagrilintide and semaglutide dosing protocols Proper dosing ensures maximum efficacy with manageable side effects

BENEFITS MAY INCLUDE: Promotes enhanced immune system function*

Geesala R

Some 76 percent of doctors surveyed use one personally or recommend them to patients